M. Collins

发表

Safety and cost analysis of an (18)FDG-PET-CT response based follow-up strategy for head and neck cancers treated with primary radiation or chemoradiation.

D. Rischin, J. Corry, K. Shah, 2015, Oral oncology.

Reducing posttreatment dysphagia: Support for the relationship between radiation dose to the pharyngeal constrictors and swallowing outcomes.

J. Corry, M. Collins, S. Senthi, 2013, Practical radiation oncology.

Weight and fat distribution in patients taking valproate: A valproate‐discordant gender‐matched twin and sibling pair study

Kate M. Lawrence, P. Sambrook, S. Berkovic, 2014, Epilepsia.

T4 squamous cell carcinoma of the oral tongue without mandibular involvement: surgery or chemoradiotherapy?

D. Rischin, Lachlan McDowell, J. Corry, 2014, Oral surgery, oral medicine, oral pathology and oral radiology.

Imaging Before and During Definitive Chemoradiation for Non-Small Cell Lung Cancer

T. Kron, D. Ball, R. Hicks, 2014 .

Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non–Small Cell Lung Cancer

T. Kron, D. Ball, R. Hicks, 2014 .

Differential 18F-FDG and 18F-FLT Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non–Small Cell Lung Cancer

T. Kron, D. Ball, R. Hicks, 2014, The Journal of Nuclear Medicine.

Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era.

R. Larson, F. Appelbaum, S. Devlin, 2014, Blood.

Assessment of predictors of response and long-term survival of patients with neuroendocrine tumour treated with peptide receptor chemoradionuclide therapy (PRCRT)

R. Hicks, M. Michael, M. Hofman, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

Frequency of fibroblast growth factor receptor 1 gene amplification in oral tongue squamous cell carcinomas and associations with clinical features and patient outcome.

S. Fox, B. Solomon, P. Russell, 2013, Oral oncology.

Quantitative methodology is critical for assessing DNA methylation and impacts on correlation with patient outcome

B. Solomon, H. Do, A. Dobrovic, 2014, Clinical Epigenetics.

Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 Trial.

D. Rischin, B. Panizza, G. Fogarty, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Endothelial progenitor cell mobilization by preoperative exercise: a bone marrow response associated with postoperative outcome.

J. Heymach, R. Mehran, R. Schier, 2014, British journal of anaesthesia.

The operating surgeon is an independent predictor of chest tube drainage following cardiac surgery.

B. Dixon, D. Campbell, A. Newcomb, 2014, Journal of cardiothoracic and vascular anesthesia.

Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia

J. Reynolds, L. Chong, P. Browett, 2012, Haematologica.

Cardiopulmonary testing predicts 5 yr survival after major surgery.

B. Riedel, H. Ismail, M. Collins, 2013, British journal of anaesthesia.

Intra-patient dose escalation in Ewing’s sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective review

David M. Thomas, J. Desai, J. Lewin, 2013, Clinical Sarcoma Research.

Sevoflurane and its role in the development of chronic postsurgical pain: where is the smoking gun?

B. Riedel, M. Collins, Jason A. Chou, 2013, Anesthesia and analgesia.

A phase II study of induction carboplatin and gemcitabine followed by chemoradiotherapy for the treatment of locally advanced nasopharyngeal carcinoma.

B. Solomon, L. Peters, R. Hicks, 2013, Oral oncology.

The association of blood transfusion with mortality after cardiac surgery: cause or confounding? (CME)

B. Dixon, D. Campbell, A. Newcomb, 2013, Transfusion.

Correlation of Ataxia-Telangiectasia-Mutated (ATM) gene loss with outcome in head and neck squamous cell carcinoma.

S. Fox, B. Solomon, L. Peters, 2012, Oral oncology.

Post-operative concurrent chemo-radiotherapy versus post-operative radiotherapy in high-risk cutaneous squamous cell carcinoma of the head and neck: A randomized phase III trial (Trans Tasman Radiation Oncology Group 05.01 Trial; POST study).

D. Rischin, B. Panizza, G. Fogarty, 2017 .

Differential mechanisms of CDKN2A (p16) alteration in oral tongue squamous cell carcinomas and correlation with patient outcome

S. Fox, B. Solomon, H. Do, 2014, International journal of cancer.

Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis.

David M. Thomas, M. Sydes, A. Bleyer, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A prospective pathologic study to define the clinical target volume for partial breast radiation therapy in women with early breast cancer.

S. Fox, M. Collins, P. Hill, 2011, International journal of radiation oncology, biology, physics.

High Donor and Recipient Age Are Not Risk Factors for Chronic Graft-Versus-Host Disease in the Setting of Anti-Thymocyte Globulin-Conditioned Hematopoietic Stem Cell Transplantation

J. Szer, I. Lewis, J. Storek, 2013 .

Older recipient age is paradoxically associated with a lower incidence of chronic GVHD in Thymoglobulin recipients: a retrospective study exploring risk factors for GVHD in allogeneic transplantation with Thymoglobulin GVHD prophylaxis

J. Szer, I. Lewis, J. Storek, 2015, Bone Marrow Transplantation.

Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial.

L. Campbell, J. Reynolds, J. Szer, 2015, The Lancet. Haematology.

Acute myeloid leukaemia relapsing after allogeneic haemopoietic stem cell transplantation: prognostic factors and impact of initial therapy of relapse

J. Szer, I. Lewis, A. M. Johnston, 2018, Internal medicine journal.

All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).

J. Reynolds, J. Szer, C. Tiley, 2012, Blood.

A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemia

J. Szer, I. Lewis, P. Marlton, 2014, British journal of haematology.

High‐dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients

J. Lewin, M. Dickinson, D. Ritchie, 2014, Internal medicine journal.

Patients treated with platinum-doublet chemotherapy for advanced non--small-cell lung cancer have inferior outcomes if previously treated with platinum-based chemoradiation.

B. Solomon, L. Mileshkin, D. Ball, 2013, Clinical lung cancer.

Clinical decision aids in colon cancer: a comparison of two predictive nomograms.

F. Kelleher, M. Collins, I. Collins, 2012, Clinical colorectal cancer.

All-trans-retinoic acid , idarubicin , and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia ( APML 4 )

J. Reynolds, J. Szer, C. Tiley, 2012 .

therapy in acute promyelocytic leukemia (APML4) -retinoic acid, idarubicin, and IV arsenic trioxide as initial trans All-

J. Reynolds, J. Szer, C. Tiley, 2013 .

68Ga-EDTA PET/CT Imaging and Plasma Clearance for Glomerular Filtration Rate Quantification: Comparison to Conventional 51Cr-EDTA

David Binns, Michael S. Hofman, Rodney J. Hicks, 2015, The Journal of Nuclear Medicine.

68 Ga-EDTA PET / CT Imaging and Plasma Clearance for Glomerular Filtration Rate Quantification : Comparison to Conventional 51 Cr-EDTA

S. Siva, R. Hicks, M. Hofman, 2015 .

(GFR) quantification: comparison to conventional Cr-51 EDTA

S. Siva, R. Hicks, M. Hofman, 2015 .

Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 Trial.

D. Rischin, B. Panizza, G. Fogarty, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomised study of a diet intervention to maintain consistent rectal volume for patients receiving radical radiotherapy to the prostate

T. Kron, F. Foroudi, M. Collins, 2014, Acta oncologica.

Final Analysis of the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 Trial: All-Trans Retinoic Acid (ATRA), Intravenous Arsenic Trioxide (ATO) and Idarubicin (IDA) As Initial Therapy for Acute Promyelocytic Leukemia (APL)

L. Campbell, J. Seymour, M. Collins, 2014 .